Provided by Tiger Trade Technology Pte. Ltd.

BioRestorative Therapies, Inc.

2.21
-0.0300-1.34%
Volume:56.83K
Turnover:125.35K
Market Cap:3.05M
PE:-0.10
High:2.24
Open:2.20
Low:2.19
Close:2.24
52wk High:34.60
52wk Low:2.01
Shares:1.38M
Float Shares:1.25M
Volume Ratio:7.57
T/O Rate:4.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-21.7566
EPS(LYR):-31.6731
ROE:-241.14%
ROA:-118.81%
PB:1.01
PE(LYR):-0.07

Loading ...

Maxim Downgrades BioRestorative Therapies to Hold From Buy

MT Newswires Live
·
2 hours ago

BioRestorative Therapies Inc : Maxim Group Cuts to Hold from Buy

THOMSON REUTERS
·
2 hours ago

BioRestorative Therapies Inc Expected to Post a Loss of $2.50 a Share - Earnings Preview

Reuters
·
Oct 02

BioRestorative Therapies VP of R&D Silva Resigns, Seeks About $1.29 Million Severance

Reuters
·
Sep 11

BioRestorative Therapies Inc Expected to Post a Loss of $2.50 a Share - Earnings Preview

Reuters
·
Sep 11

BioRestorative Amends 8-K to Clarify Auditor Change, Audit Committee Probe Scope

Reuters
·
Sep 11

BioRestorative Therapies Inc trading halted, news pending

TIPRANKS
·
Sep 05

BioRestorative Therapies Inc Expected to Post a Loss of 12 Cents a Share - Earnings Preview

Reuters
·
Sep 04

BioRestorative Therapies announces 1-for-20 reverse stock split

TIPRANKS
·
Sep 03

Biorestorative Therapies Announces Reverse Stock Split

Reuters
·
Sep 03

BioRestorative Therapies Announces Reverse Stock Split

THOMSON REUTERS
·
Sep 03

BioRestorative Therapies - Appoints Steven Brown as Chairman of the Board Effective September 1, 2026 - SEC Filing

THOMSON REUTERS
·
Sep 02

BioRestorative Therapies - Katharyn Field Steps Aside as Interim CEO and CFO Effective August 26, 2026 - SEC Filing

THOMSON REUTERS
·
Sep 02

BioRestorative Therapies Inc: Appoints Anna Skowron as Chief Financial Officer, Effective August 27, 2026

THOMSON REUTERS
·
Sep 02

BioRestorative Therapies Switches Auditor to Bush & Associates CPA, Dismisses CBIZ CPAs

Reuters
·
Sep 02

BioRestorative Therapies Gets NASDAQ Notice over Late Filing of Quarterly Report

Reuters
·
Aug 26

BioRestorative Therapies Inc Expected to Post a Loss of 12 Cents a Share - Earnings Preview

Reuters
·
Aug 19

BioRestorative Therapies Delays Q2 10-Q Filing After CEO, CFO Resignations

Reuters
·
Aug 15

BioRestorative Therapies: Has not Made Decision to Discontinue Suspended Product Lines - SEC Filing

THOMSON REUTERS
·
Aug 15

BioRestorative Therapies: Conducting Review of the Documentation, Sourcing, Regulatory Status Associated with Suspended Products- SEC Filing

THOMSON REUTERS
·
Aug 15